Evidence map›Paper›PMID 30948450›Full record

ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2019

Genome-wide Analysis of Common Copy Number Variation and Epithelial Ovarian Cancer Risk.

Brett M Reid, Jennifer B Permuth, Y Ann Chen, Brooke L Fridley, Edwin S Iversen, Zhihua Chen, Heather Jim, Robert A Vierkant, Julie M Cunningham, Jill S Barnholtz-Sloan and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Human Orphan Cytochromes P450: An Update.Current drug metabolism · 2022
    Article
  15. Article
  16. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 2 countries.

Brett M ReidMoffitt Cancer Center and Research Institute, Tampa, Florida.
Jennifer B PermuthMoffitt Cancer Center and Research Institute, Tampa, Florida.ORCID 0000-0002-4726-9264
Y Ann ChenMoffitt Cancer Center and Research Institute, Tampa, Florida.
Brooke L FridleyMoffitt Cancer Center and Research Institute, Tampa, Florida.
Edwin S IversenDuke University Medical Center, Durham, North Carolina.
Zhihua ChenMoffitt Cancer Center and Research Institute, Tampa, Florida.
Heather JimMoffitt Cancer Center and Research Institute, Tampa, Florida.
Robert A VierkantMayo Clinic College of Medicine, Rochester, Minnesota.
Julie M CunninghamMayo Clinic College of Medicine, Rochester, Minnesota.ORCID 0000-0002-8159-3025
Jill S Barnholtz-SloanCase Comprehensive Cancer Center, Cleveland, Ohio.
Steven NarodCenter for Research in Women's Health, Toronto, Ontario, Canada.
Harvey RischYale School of Public Health, New Haven, Connecticut.
Joellen M SchildkrautUniversity of Virginia, Charlottesville, Virginia.
Ellen L GoodeMayo Clinic College of Medicine, Rochester, Minnesota.
Alvaro N MonteiroMoffitt Cancer Center and Research Institute, Tampa, Florida.ORCID 0000-0002-8448-4801
Thomas A SellersMoffitt Cancer Center and Research Institute, Tampa, Florida. thomas.sellers@moffitt.org.
Moffitt Cancer Center · USMayo Clinic · USCase Comprehensive Cancer CenterCoalition for Research in Women's Health · CADuke Medical Center · USNew Haven Public Schools · USUniversity of Virginia · US

Funding

Women's Cancer ProgramP30CA015083 · NCI · MAYO CLINIC ROCHESTER · PI AKHILESH PANDEY · 1985 to 2026
$151.3M
Use of microfluidic tumor cultures to enable clinical trials of therapies for ovarian cancerP50CA136393 · NCI · MAYO CLINIC ROCHESTER · PI ELLEN L. GOODE · 2009 to 2026
$37.0M
Ovarian cancer GWAS discovery, expansion and replication (N2 - Project #1)U19CA148112 · NCI · H. LEE MOFFITT CANCER CTR & RES INST · PI SELLERS, THOMAS A · 2010 to 2014
$10.2M
Haplotype-Based Genome Screen for Ovarian Cancer LociR01CA114343 · NCI · H. LEE MOFFITT CANCER CTR & RES INST · PI SELLERS, THOMAS A · 2007 to 2011
$7.5M
The Molecular Epidemiology Of Ovarian CancerR01CA076016 · NCI · DUKE UNIVERSITY · PI SCHILDKRAUT, JOELLEN M. · 1998 to 2010
$6.2M
Population-Based Analysis of Ovarian Cancer BiomarkersR01CA106414 · NCI · UNIVERSITY OF SOUTH FLORIDA · PI SUTPHEN, REBECCA · 2005 to 2009
$3.0M
Genetic Variation in the NF-kappaB Pathway and Ovarian Cancer EtiologyR01CA122443 · NCI · MAYO CLINIC ROCHESTER · PI GOODE, ELLEN L. · 2007 to 2012
$2.7M
NCI NIH HHS P30 CA015083NCI NIH HHS P50 CA136393NCI NIH HHS R01 CA076016NCI NIH HHS R01 CA106414NCI NIH HHS R01 CA114343NCI NIH HHS R01 CA122443NCI NIH HHS U19 CA148112
6 · The paper itself

Abstract

backgroundGermline DNA copy number variation (CNV) is a ubiquitous source of genetic variation and remains largely unexplored in association with epithelial ovarian cancer (EOC) risk.

methodsCNV was quantified in the DNA of approximately 3,500 cases and controls genotyped with the Illumina 610k and HumanOmni2.5M arrays. We performed a genome-wide association study of common (>1%) CNV regions (CNVRs) with EOC and high-grade serous (HGSOC) risk and, using The Cancer Genome Atlas (TCGA), performed

resultsThree CNVRs were associated (

conclusionsThough CNV appears to not contribute largely to EOC susceptibility, a number of low-to-common frequency variants may influence the risk of EOC and tumor-gene expression. IMPACT: Further research on CNV and EOC susceptibility is warranted, particularly with CNVs estimated from high-density arrays.

Indexed as

Carcinoma, Ovarian EpithelialCase-Control StudiesDNA Copy Number VariationsFemaleGenome-Wide Association StudyHumans

Identifiers

PMID30948450
PMCPMC6606353
OpenAlexW2934861714

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.